5,231 Shares in Intuitive Surgical, Inc. $ISRG Bought by NRI Wealth Management LC

NRI Wealth Management LC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, Holdings Channel.com reports. The firm purchased 5,231 shares of the medical equipment provider’s stock, valued at approximately $2,843,000. Intuitive Surgical accounts for 1.7% of NRI Wealth Management LC’s investment portfolio, making the stock its 13th largest holding.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after purchasing an additional 453,335 shares in the last quarter. Invesco Ltd. increased its stake in Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after buying an additional 71,794 shares during the last quarter. Northern Trust Corp increased its stake in Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after buying an additional 11,988 shares during the last quarter. Wellington Management Group LLP lifted its position in Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after buying an additional 457,080 shares in the last quarter. Finally, Nuveen LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter worth about $1,715,899,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Wells Fargo & Company lifted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research report on Wednesday, July 23rd. Truist Financial boosted their price target on Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Piper Sandler reissued an “overweight” rating and issued a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Finally, UBS Group upped their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $594.19.

Insider Transactions at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the transaction, the director directly owned 739 shares in the company, valued at approximately $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock worth $21,716,492 over the last quarter. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $438.04 on Thursday. The company has a market cap of $157.03 billion, a P/E ratio of 61.09, a P/E/G ratio of 4.69 and a beta of 1.61. The firm’s fifty day moving average price is $465.33 and its two-hundred day moving average price is $500.54. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the previous year, the firm posted $1.78 EPS. Intuitive Surgical’s revenue was up 21.4% compared to the same quarter last year. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.